• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lung cancer and the immune system-current controversies and future opportunities.

作者信息

Steinfort Daniel P

机构信息

Department Respiratory Medicine, Royal Melbourne Hospital, Parkville, Australia.

Department of Medicine, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Australia.

出版信息

Transl Lung Cancer Res. 2021 Jun;10(6):2733-2735. doi: 10.21037/tlcr-21-434.

DOI:10.21037/tlcr-21-434
PMID:34295673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8264337/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ea/8264337/fc267ad49aaa/tlcr-10-06-2733-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ea/8264337/fc267ad49aaa/tlcr-10-06-2733-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ea/8264337/fc267ad49aaa/tlcr-10-06-2733-fa.jpg

相似文献

1
Lung cancer and the immune system-current controversies and future opportunities.肺癌与免疫系统——当前的争议及未来机遇
Transl Lung Cancer Res. 2021 Jun;10(6):2733-2735. doi: 10.21037/tlcr-21-434.
2
EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.非小细胞肺癌细胞学样本中的 EGFR 基因状况：争议与机遇。
Cancer Cytopathol. 2011 Apr 25;119(2):80-91. doi: 10.1002/cncy.20150. Epub 2011 Mar 11.
3
Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.表皮生长因子受体突变型非小细胞肺癌的免疫检查点抑制剂：当前的争议和未来的方向。
Lung Cancer. 2018 Jan;115:12-20. doi: 10.1016/j.lungcan.2017.11.009. Epub 2017 Nov 13.
4
Technologic advances in breast imaging. Current and future strategies, controversies, and opportunities.乳腺成像技术的进展。当前及未来的策略、争议与机遇。
Surg Oncol Clin N Am. 1997 Apr;6(2):403-9.
5
To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade.做还是不做：免疫检查点阻断当前临床争议的简要更新
J Oncol Pharm Pract. 2019 Apr;25(3):663-673. doi: 10.1177/1078155218786365. Epub 2018 Jul 12.
6
First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress.非小细胞肺癌的一线免疫检查点抑制剂：现状与未来进展
Front Pharmacol. 2020 Oct 7;11:578091. doi: 10.3389/fphar.2020.578091. eCollection 2020.
7
Staging of non-small cell lung cancer: consensus, controversies and challenges.非小细胞肺癌的分期：共识、争议与挑战
Lung Cancer. 2001 Dec;34 Suppl 2:S95-107. doi: 10.1016/s0169-5002(01)00356-7.
8
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm.PD-1/PD-L1 轴免疫检查点抑制剂在非小细胞肺癌中的应用：新型治疗模式中的前景、争议和不确定性。
Scand J Clin Lab Invest. 2020 Sep;80(5):360-369. doi: 10.1080/00365513.2020.1742369. Epub 2020 Apr 2.
9
Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives.晚期非小细胞肺癌的全身治疗：争议与展望
Memo. 2018;11(2):112-115. doi: 10.1007/s12254-018-0408-y. Epub 2018 May 18.
10
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.干细胞、细胞疗法和生物工程在肺生物学和疾病中的应用。对 2010-2012 年近期文献的综合回顾。
Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.

本文引用的文献

1
Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation.支气管镜热蒸汽消融术后非小细胞肺癌肿瘤PD-L1表达增加。
Transl Lung Cancer Res. 2021 Jun;10(6):2858-2864. doi: 10.21037/tlcr-21-76.
2
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors.非小细胞肺癌的热消融：治疗方式综述及与免疫检查点抑制剂联合应用的证据
Transl Lung Cancer Res. 2021 Jun;10(6):2842-2857. doi: 10.21037/tlcr-20-1075.
3
B cells in lung cancer-not just a bystander cell: a literature review.
肺癌中的B细胞——并非只是旁观者细胞：文献综述
Transl Lung Cancer Res. 2021 Jun;10(6):2830-2841. doi: 10.21037/tlcr-20-788.
4
Holding our breath: the promise of tissue-resident memory T cells in lung cancer.屏住呼吸：组织驻留记忆T细胞在肺癌中的前景
Transl Lung Cancer Res. 2021 Jun;10(6):2819-2829. doi: 10.21037/tlcr-20-819.
5
Emerging and multifaceted role of neutrophils in lung cancer.中性粒细胞在肺癌中新兴的多方面作用
Transl Lung Cancer Res. 2021 Jun;10(6):2806-2818. doi: 10.21037/tlcr-20-760.
6
Exploring natural killer cell immunology as a therapeutic strategy in lung cancer.探索自然杀伤细胞免疫学作为肺癌治疗策略。
Transl Lung Cancer Res. 2021 Jun;10(6):2788-2805. doi: 10.21037/tlcr-20-765.
7
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer.将支气管内超声支气管镜检查与非小细胞肺癌免疫治疗生物标志物的分子检测相结合。
Transl Lung Cancer Res. 2021 Jun;10(6):2779-2787. doi: 10.21037/tlcr-20-781.
8
A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer.转移性非小细胞肺癌中立体定向消融放疗与免疫治疗联合应用的叙述性综述。
Transl Lung Cancer Res. 2021 Jun;10(6):2766-2778. doi: 10.21037/tlcr-20-1117.
9
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.免疫检查点抑制剂治疗后肺部毒性的已知与未知：一篇叙述性综述
Transl Lung Cancer Res. 2021 Jun;10(6):2752-2765. doi: 10.21037/tlcr-20-806.
10
Immunotherapy in oncogene addicted non-small cell lung cancer.针对癌基因成瘾性非小细胞肺癌的免疫疗法。
Transl Lung Cancer Res. 2021 Jun;10(6):2736-2751. doi: 10.21037/tlcr-20-772.